Literature DB >> 6087343

Nucleotide sequence 5' of the chicken c-myc coding region: localization of a noncoding exon that is absent from myc transcripts in most avian leukosis virus-induced lymphomas.

C K Shih, M Linial, M M Goodenow, W S Hayward.   

Abstract

We have determined the nucleotide sequence of the 2.2-kilobase-pair region upstream of the chicken c-myc coding exons. Using RNA blot analysis, we have localized a noncoding exon to a region that is separated from the c-myc coding sequences by an intron of 700-800 base pairs. In most avian leukosis virus-induced lymphomas proviral integration has occurred within, or downstream of, the first exon, thus presumably displacing the regulatory sequences that normally control c-myc expression. More than 70% of the integration sites were clustered in a 250-base-pair region in the first intron, immediately preceding the coding sequences. Sequences from the upstream noncoding exon were absent from the myc transcripts in these lymphomas; RNA transcripts from the normal c-myc allele were not expressed at detectable levels.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6087343      PMCID: PMC391557          DOI: 10.1073/pnas.81.15.4697

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Nucleotide sequence to the v-myc oncogene of avian retrovirus MC29.

Authors:  K Alitalo; J M Bishop; D H Smith; E Y Chen; W W Colby; A D Levinson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

2.  Mechanism of activation of a human oncogene.

Authors:  C J Tabin; S M Bradley; C I Bargmann; R A Weinberg; A G Papageorge; E M Scolnick; R Dhar; D R Lowy; E H Chang
Journal:  Nature       Date:  1982-11-11       Impact factor: 49.962

3.  Orientation and position of avian leukosis virus DNA relative to the cellular oncogene c-myc in B-lymphoma tumors of highly susceptible 15I5 X 7(2) chickens.

Authors:  Y K Fung; L B Crittenden; H J Kung
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

4.  Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line.

Authors:  S Collins; M Groudine
Journal:  Nature       Date:  1982-08-12       Impact factor: 49.962

5.  Novel myc oncogene RNA from abortive immunoglobulin-gene recombination in mouse plasmacytomas.

Authors:  G L Shen-Ong; E J Keath; S P Piccoli; M D Cole
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

6.  Translocation of immunoglobulin VH genes in Burkitt lymphoma.

Authors:  J Erikson; J Finan; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

7.  Molecular analysis of the c-myc locus in normal tissue and in avian leukosis virus-induced lymphomas.

Authors:  B G Neel; G P Gasic; C E Rogler; A M Skalka; G Ju; F Hishinuma; T Papas; S M Astrin; W S Hayward
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

8.  Isolation and characterization of c-myc, a cellular homolog of the oncogene (v-myc) of avian myelocytomatosis virus strain 29.

Authors:  B Vennstrom; D Sheiness; J Zabielski; J M Bishop
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

9.  Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.

Authors:  R Dalla-Favera; M Bregni; J Erikson; D Patterson; R C Gallo; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

10.  Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells.

Authors:  R Taub; I Kirsch; C Morton; G Lenoir; D Swan; S Tronick; S Aaronson; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

View more
  36 in total

1.  Structural analysis of length mutations in a hot-spot region of wheat chloroplast DNAs.

Authors:  Y Ogihara; T Terachi; T Sasakuma
Journal:  Curr Genet       Date:  1992-09       Impact factor: 3.886

2.  Transcriptionally active genome regions are preferred targets for retrovirus integration.

Authors:  U Scherdin; K Rhodes; M Breindl
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

3.  Proviral insertions within the int-2 gene can generate multiple anomalous transcripts but leave the protein-coding domain intact.

Authors:  C Dickson; R Smith; S Brookes; G Peters
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

4.  5' long terminal repeats of myc-associated proviruses appear structurally intact but are functionally impaired in tumors induced by avian leukosis viruses.

Authors:  M M Goodenow; W S Hayward
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

5.  Identification of the human c-myc protein nuclear translocation signal.

Authors:  C V Dang; W M Lee
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

6.  Absence of missense mutations in activated c-myc genes in avian leukosis virus-induced B-cell lymphomas.

Authors:  M Hahn; W S Hayward
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

7.  Molecular cloning of proviral DNA and structural analysis of the transduced myc oncogene of avian oncovirus CMII.

Authors:  N Walther; R Lurz; T Patschinsky; H W Jansen; K Bister
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

8.  Structure and transforming function of transduced mutant alleles of the chicken c-myc gene.

Authors:  T Patschinsky; H W Jansen; H Blöcker; R Frank; K Bister
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

9.  Avian proto-myc genes promoted by defective or nondefective retroviruses are single-hit transforming genes in primary cells.

Authors:  R P Zhou; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

10.  Differential selection of cells with proviral c-myc and c-erbB integrations after avian leukosis virus infection.

Authors:  M Gong; H L Semus; K J Bird; B J Stramer; A Ruddell
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.